One of the challenges of working in an industry that moves at the speed of light is keeping up with all of the changes. I mentioned to a several friends of mine that I’m a heavy user of Google Reader and we decided to form a Journal Club. A Journal Club is a way for […]
Creating a Journal Club With Google Reader Read More »
Every year the journal Nucleic Acids Research publishes a Database Edition that contains listings for hundreds of bioinformatics-related databases. It’s an invaluable snapshot of the current state-of-the-art databases, and it’s available free of charge under NAR’s Open Access policy. Recently, they added a Web Server edition which describes the web applications currently available. Both editions
Nucleic Acids Research Database Edition Read More »
Dr. Nick recently posted a blog entry describing the need for a change to the approach used to develop to new cancer therapeutics. Echoing a point made by Dr. Stephen Neidle (Dir. of Cancer Drug Development at the University of London), he says that most of the low-hanging fruit has been harvested. During the early part
A New Approach To Cancer Drug Development Read More »
I’m sure Kipling will forgive me for hacking the title of his poem, but I’ve been having a lot of fun recently with Mendeley as part of my ongoing “Free Software for Scientists” blog series. Although Mendeley is not completely free, it’s certainly free to download and use. Mendeley has a tiered pricing plan that
The Road To Mendeley Read More »
I’ve been attending a number of meetings over the past few weeks and one of the themes that I hear echoed from both scientists and software engineers is the need to stay current with the latest developments in their fields. When I ask how they’re currently doing it the responses vary, but it usually comes
HiveMind: A Tool For Collaborative Science Read More »
There’s been a lot of traffic over the past couple of weeks with respect to Open Access Science. It started with Phil Bourne’s article on what the future of open access science might look like. Dr. Bourne is the Editor of PLoS Computational Biology and a long-time advocate of Open Access journals. His article highlights some
Open Access Science ?= Open Source Software Read More »
I was talking with some friends recently about who uses Twitter (and more importantly who doesn’t). I found that you could almost predict which scientists would be Twitter users based on the amount of socializing they did in the real world. Some of the biotech and pharma companies that I’ve worked for had a Friday
Why Twitter Should Matter To Scientists Read More »
Over the past two years, the recession has had a profound impact on the pharmaceutical industry. Out of the ashes though new startup opportunities have arisen for scientists with experience in drug discovery. These startups in turn are feeding the ever-diminishing pipelines of big pharma. As with every startup company though, cashflow is always a
Free Software For Scientists – BioBar Read More »
Last year cloud computing has become a major topic of conversation in drug discovery companies. At the San Diego Bioinformatics Forum this year, Sandor Szalma gave a great presentation on how cloud computing was used at his company, Centocor (a division of Johnson and Johnson). Just prior to his talk, BioITWorld featured a article on
Cloud Computing for Drug Discovery Read More »
